No Data
No Data
Shinva Medical Instrument (600587): An analysis of profit margin improvement from the perspective of Shinva Medical Instrument.
Investment highlights: Shinva Medical Instrument is a leading domestic medical instrument enterprise, with the background of state-owned enterprise reform, the product is switching to high-end market rapidly, and the profitability is improving quickly. We believe that the market has insufficient recognition of the company's product strength, and the company has a large number of invention patents and is currently in the production.
Shinva Medical Instrument Gets China Nod for Radiotherapy Device
Did you win the lawsuit but have trouble receiving the payment? Shinva Medical Instrument expects international revenue growth to exceed 30% this year. | Earnings conference highlights.
① In February 2023, the lawsuit between Xinhua Medical and Chengdu Yingde regarding performance compensation reached a final judgment, but the company has yet to receive full compensation. ② In terms of international business, Li Caixiang, director of the company, said that the company's international revenue is expected to increase by no less than 30% this year compared to 2023. ③ The company responded to issues such as the impact of the trade-in policy on the company and business development in the field of endoscopy.
Shinva Medical Instrument Gets Nod to Register Surgical Endoscope
Xinhua Healthcare (600587.SH) 2023 equity distribution: 0.50 yuan per share to increase 0.30 shares to be registered on June 5
Xinhua Healthcare (600587.SH) issued the 2023 equity distribution implementation notice. The current profit distribution and transfer...
Xinhua Healthcare (600587.SH): Currently focusing on the middle and downstream links of the synthetic biology industry chain
Gelonghui, May 15 | Xinhua Healthcare (600587.SH) said on an interactive platform that the company is currently focusing on the middle and downstream aspects of the synthetic biology industry chain. The company provides comprehensive support from basic research to industrialization for every application scenario of customers, including high-quality core process equipment, auxiliary process equipment, design, engineering and other products and services. Through a one-stop BPC overall solution. Empower synthetic biology companies to achieve effective commercialization of products and increase efficiency.
No Data